Open AccessSodium-glucose cotransporter 2 inhibitor use: A pharmaco-ergonomic qualification tool
Author(s) -
Sanjay Kalra,
AG Unnikrishnan,
Manash P Baruah,
Pallavi Kawatra,
Jignesh Ved
Publication year - 2017
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_184_17
Subject(s) - medicine , type 2 diabetes , pharmacology , diabetes mellitus , intensive care medicine , risk analysis (engineering) , endocrinology
Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize the pharmaco-ergonomic considerations for these agents, in the form of an SGLT2-i qualification tool, based on a clinical score. This tool may serve as a simple and inexpensive practical guide, to optimize the risk-benefit considerations for SGLT2-i agents.